John Oates

John Oates has a diverse work experience spanning over several years. John co-founded and served as CEO of Recombination Therapeutics since 2018. In the same year, they also held the roles of COO & CFO at Opsidio, LLC. Prior to these positions, they were a member of Mid Atlantic Bio Angels in 2016 and worked as an investor, advisor, and life sciences executive in their self-employed capacity since 2010. From 2006 to 2010, they served as the General Manager of Biotechnology Solutions at United BioSource Corporation. Before that, they held the positions of COO & CFO at BioCor from 2000 to 2006. John'searliest work experience was as a Financial Analyst/Operations Officer at Citibank from 1995 to 1998.

John Oates attended the Alfred Lerner College of Business & Economics at the University of Delaware. However, no information regarding the specific years of study, degree earned, or field of study is available.